2 ML Gamifant 5 MG/ML Injection
- RxCUI
- 2104616
- RxNorm name
- 2 ML Gamifant 5 MG/ML Injection
- Display name
- 2 ML Gamifant 5 MG/ML Injection
- Full name
- 2 ML Gamifant 5 MG/ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:14
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761107 | Gamifant | emapalumab-lzsg | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GAMIFANT | EMAPALUMAB-LZSG | Swedish Orphan Biovitrum AB (publ) | a865e0ef-8685-4f69-8838-648c4f3bab47 | 2026-03-26 | Warnings, Adverse reactions | 2104616 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a865e0ef-8685-4f69-8838-648c4f3bab47 | Gamifant 10 MG in 2 ML Injection [PSN] · 2 ML emapalumab-lzsg 5 MG/ML Injection [Gamifant] [SBD] · 2 ML Gamifant 5 MG/ML Injection [SY] · Gamifant 10 MG per 2 ML Injection [SY] | 4 | 10 | These highlights do not include all the information needed to use GAMIFANT safely and effectively. See full prescribing information for GAMIFANT. GAMIFANT ® (emapalumab-lzsg) injection, for intravenous use Initial U.S. Approval: 2018 | 20260326 |